Quantum BioPharma files amended 6-K to incorporate Aug. 10 press release into Form F-3 registration statement
QNTM•No changes to original disclosure
No other disclosures from the original Aug. 10 filing were modified or updated.
Amended filing re-furnishes press release
Quantum BioPharma filed an amended Form 6-K to re-furnish its Aug. 10, 2026 press release as Exhibit 99.1.
The amendment aimed to incorporate the press release into its Form F-3 registration statement (File No. 333-276264).
